Abiopharma

Morningstar Report Finds Semiliquid Fund Market Nears $600 Billion as Private Credit Loses Steam

QuickLogic to Participate in the Northland Growth Conference 2026

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Calidi Biotherapeutics - Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Teledyne to Participate at the TD Cowen U.S. Corporate Access Day Conference

Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets

CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy

ONE Nuclear Announces Strategic Collaboration with Sunshine Partners to Develop Joint Power Projects in West Texas